Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ:…
Hong Kong watchdog investigates Cloudbreak Pharma for 'rigged' IPO
Hong Kong's Securities and Futures Commission (SFC) has directed the stock exchange to suspend trading of US-based biotech firm Cloudbreak Pharma pending an investigation into its US$78 million initial public offering (IPO) last year. “The…
SFC orders biotech firm Cloudbreak Pharma to suspend trading
The Securities and Futures Commission has directed the stock exchange of Hong Kong to suspend all dealing in the shares of Cloudbreak Pharma (2592), effective at 9:00 am on Thursday. SCROLL TO CONTINUE WITH CONTENT The regulatory action was…
SFC orders biotech firm Cloudbreak Pharma to suspend trading over suspected IPO rigging
The Securities and Futures Commission has directed the stock exchange of Hong Kong to suspend all dealing in the shares of Cloudbreak Pharma (2592) over suspected IPO rigging, effective at 9:00 am on Thursday. SCROLL TO CONTINUE WITH CONTENT Under…
IHE: Large-Cap Pharma Cools After A Hot Summer (NYSEARCA:IHE)
I issue a hold rating on the iShares US Pharmaceuticals ETF due to fair valuation and mounting near-term headwinds. IHE's portfolio is highly concentrated, with 43% in JNJ and LLY and top 10 holdings totaling 76%. Technical trends have turned…
DeepIntent Releases Agentic Ad Platform As Pharma Marketing Grows More Complex
The future of brands gets decided here. Join the industry's top marketers at Brandweek for the ideas, insights, and connections shaping what's next. Get your ticket. Last year, the digital ad buying platform DeepIntent sold a majority stake to…
LSL PHARMA GROUP ANNOUNCES CFO TRANSITION
BOUCHERVILLE, QC, Sept. 10, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced that Luc Mainville will be leaving his position as Chief Financial…
BridgeBio Pharma Stock: Attruby Peak Sales Set To Rise (NASDAQ:BBIO)
BridgeBio Pharma has delivered multiple clinical and commercial successes, yet shares have repeatedly sold off after positive catalysts. Infigratinib's dwarfism trial outperformed the market leader, and Attruby continues to beat sales estimates…
Innocan Pharma Announces Private Placement of Units
HERZLIYA, Israel and CALGARY, Alberta, Sept. 9, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan') is pleased to announce that it intends to complete a private placement of up to 535,000 units…
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
The Fidelity MSCI Health Care Index ETF (FHLC -0.42%) provides broad healthcare exposure at a fraction of the cost of the State Street SPDR S&P Pharmaceuticals ETF (XPH -1.51%), which targets a specific industry niche. Investors seeking healthcare…
HC Wainwright Reiterates 'Buy' Rating for BridgeBio Pharma (NASDAQ:BBIO)
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report)'s stock had its 'buy' rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They presently have a $120.00 target price on the stock. HC…
Innate Pharma (IPHA) Projected to Post Quarterly Earnings on Thursday
Innate Pharma (NASDAQ:IPHA - Get Free Report) will likely be announcing its Q2 2026 results before the market opens on Thursday, September 17th. Analysts expect Innate Pharma to announce earnings of ($0.2946) per share and revenue of $6.3530…
NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 52-Week Low on Insider Selling
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report)'s share price hit a new 52-week low during trading on Thursday after an insider sold shares in the company. The stock traded as low as $22.34 and last traded at $22.79, with a volume…
John Smither Sells 1,600 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director John Smither sold 1,600 shares of the firm's stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $25.32, for a total transaction…
Squarepoint Ops LLC Decreases Stock Holdings in Royalty Pharma PLC $RPRX
Squarepoint Ops LLC reduced its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 75.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 326,641 shares of the biopharmaceutical company's…
Receive a Daily briefing on Pharma Industry News
Get Started